title: The economics of stone disease.
abstract: The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.
authors.affiliation: Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9110, USA.
authors.forename: Noah E
authors.initials: NE
authors.lastname: Canvasser
authors.affiliation: Department of Urology, Mannheim University Hospital, Mannheim, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Alken
authors.affiliation: Department of Urology, Duke University, Durham, NC, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Lipkin
authors.affiliation: Department of Urology, University of Wisconsin, Madison, WI, USA.
authors.forename: Stephen Y
authors.initials: SY
authors.lastname: Nakada
authors.affiliation: Department of Urology, RG Stone Urology and Laparoscopy Hospital, Andheri, Mumbai, India.
authors.forename: Hiren S
authors.initials: HS
authors.lastname: Sodha
authors.affiliation: Department of Urology, Sen Jorj Austria Hospital, Beyoglu, Istanbul, Turkey.
authors.forename: Abdulkadir
authors.initials: A
authors.lastname: Tepeler
authors.affiliation: Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9110, USA. yair.lotan@utsouthwestern.edu.
authors.forename: Yair
authors.initials: Y
authors.lastname: Lotan
mesh_terms: D000072700:Conservative Treatment / Q000191:economics*; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D008096:Lithotripsy / Q000191:economics*; D053040:Nephrolithiasis / Q000191:economics* / Q000628:therapy; D009403:Nephrostomy, Percutaneous / Q000191:economics*; D014514:Ureteral Calculi / Q000191:economics* / Q000628:therapy; D052878:Urolithiasis / Q000191:economics / Q000628:therapy
keywords: Cost; Economics; Kidney stones; Nephrolithiasis